When you volunteer for a clinical trial, you help bring us closer to Alzheimer’s treatment and prevention discoveries.
News & Events
CMS announces plan to ensure availability of new Alzheimer’s drugs
Agency outlines how people with Medicare can get these drugs if FDA grants traditional approval.
Case study unlocks clues to rare resilience to Alzheimer’s disease
NIH-funded case study investigates resilience to a rare genetic form of early onset Alzheimer's disease.
Insomnia drug may lower levels of Alzheimer’s proteins
In a small study, a drug called suvorexant that is approved to treat insomnia reduced levels of proteins associated with Alzheimer’s disease in cerebrospinal fluid.
